Noora (vaccine)
Noora () is a COVID-19 vaccine candidate developed by Baqiyatallah University of Medical Sciences in collaboration with Plasma Darman Sarv Sepid Co. (lit. White Cypress Plasma Treatment) in Iran. Medical uses It requires three doses given by intramuscular injection on days 0, 21 and 35. Pharmacology Noora is a recombinant RBD protein subunit vaccine. Manufacturing Up to 8 December 2021, 5 millions doses have been produced. Clinical trials See also Pharmaceuticals in Iran COVID-19 pandemic in Iran COVID-19 vaccine clinical research References Iranian COVID-19 vaccines Science and technology in Iran Protein subunit vaccines